Sakar Healthcare
Sakar Healthcare Performance
Day Range
- Low 387.10
- High 394.05
52 Week Range
- Low 185.55
- High 419.50
- Open Price394.05
- Previous Close391.45
- Volume13625
Start SIP in Sakar Healthcare
Start SIPSakar Healthcare Investment Rating
-
Master Rating:
-
Sakar Healthcare has an operating revenue of Rs. 147.18 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 13% is healthy, ROE of 7% is fair but needs improvement. The company has a debt to equity of 57%, which is bit higher. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 36% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -2% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 80 which is a GOOD score indicating consistency in earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 122 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 34 | 39 | 41 | 33 | 31 | 29 | 37 |
| Operating Expenses Qtr Cr | 25 | 30 | 33 | 25 | 22 | 21 | 27 |
| Operating Profit Qtr Cr | 9 | 9 | 8 | 9 | 9 | 8 | 9 |
| Depreciation Qtr Cr | 4 | 5 | 4 | 4 | 4 | 4 | 3 |
| Interest Qtr Cr | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Tax Qtr Cr | 1 | 1 | 0 | 1 | 2 | 1 | -3 |
| Net Profit Qtr Cr | 4 | 3 | 4 | 4 | 2 | 3 | 9 |
Sakar Healthcare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹383.76
- 50 Day
- ₹363.85
- 100 Day
- ₹337.46
- 200 Day
- ₹301.33
- 20 Day
- ₹385.77
- 50 Day
- ₹358.93
- 100 Day
- ₹333.35
- 200 Day
- ₹284.36
Sakar Healthcare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 392.73 |
| Second Resistance | 396.87 |
| Third Resistance | 399.68 |
| RSI | 56.14 |
| MFI | 59.68 |
| MACD Single Line | 11.85 |
| MACD | 10.62 |
| Support | |
|---|---|
| First Resistance | 385.78 |
| Second Resistance | 382.97 |
| Third Resistance | 378.83 |
Sakar Healthcare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 13,625 | 919,960 | 67.52 |
| Week | 27,642 | 1,697,772 | 61.42 |
| 1 Month | 45,272 | 2,406,194 | 53.15 |
| 6 Month | 48,104 | 2,311,879 | 48.06 |
Sakar Healthcare Result Highlights
Sakar Healthcare Synopsis
NSE-Medical-Ethical Drugs
Sakar Healthcare is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 133.36 Cr. and Equity Capital is Rs. 19.04 Cr. for the Year ended 31/03/2023. Sakar Healthcare Ltd. is a Public Limited Listed company incorporated on 26/03/2004 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ2004PLC043861 and registration number is 043861.| Market Cap | 830 |
| Sales | 147 |
| Shares in Float | 0.98 |
| No of funds | 4 |
| Yield |
| Book Value | 4.27 |
| U/D Vol ratio | 1.7 |
| LTDebt / Equity | 57 |
| Alpha | 0.12 |
| Beta | 1.6 |
Sakar Healthcare
| Owner Name | Sep-23 | Jun-23 | Mar-23 | Feb-23 |
|---|---|---|---|---|
| Promoters | 54.15% | 60.72% | 60.72% | 60.72% |
| Mutual Funds | ||||
| Insurance Companies | ||||
| Foreign Portfolio Investors | 14.03% | 15.74% | 15.74% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 16.37% | 18.13% | 18.41% | 18.39% |
| Others | 15.45% | 21.15% | 5.13% | 5.15% |
Sakar Healthcare Management
| Name | Designation |
|---|---|
| Mr. Sanjay S Shah | Chairman & Managing Director |
| Mr. Aarsh S Shah | Joint Managing Director |
| Ms. Rita S Shah | Whole Time Director |
| Mr. Shailesh B Patel | Ind. Non-Executive Director |
| Mr. Prashant C Srivastav | Ind. Non-Executive Director |
| Mr. Hemendra C Shah | Ind. Non-Executive Director |
Sakar Healthcare Forecast
Price Estimates
Sakar Healthcare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-11-06 | Quarterly Results | |
| 2023-05-26 | Audited results | |
| 2023-02-10 | Quarterly Results | |
| 2023-01-21 | Others | To consider raising of funds |
| 2022-10-22 | Quarterly Results |
Sakar Healthcare FAQs
What is Share Price of Sakar Healthcare ?
Sakar Healthcare share price is ₹388 As on 02 December, 2023 | 17:17
What is the Market Cap of Sakar Healthcare ?
The Market Cap of Sakar Healthcare is ₹829.7 Cr As on 02 December, 2023 | 17:17
What is the P/E ratio of Sakar Healthcare ?
The P/E ratio of Sakar Healthcare is 57.6 As on 02 December, 2023 | 17:17
What is the PB ratio of Sakar Healthcare ?
The PB ratio of Sakar Healthcare is 4.8 As on 02 December, 2023 | 17:17